0001104659-26-043799
SEC filingX-energy is a developer of advanced small modular nuclear reactors (Xe-100) and proprietary TRISO-X nuclear fuel, operating at the pre-commercial deployment stage with no reactors yet delivered or final investment decisions secured; this S-1/A offering establishes its public listing and Up-C structure to fund continued development and first-of-a-kind deployments.
X-energy is a pre-revenue, pre-commercial deployment advanced nuclear technology company pioneering the Xe-100—a high-temperature gas-cooled small modular reactor—and TRISO-X, a proprietary spherical pebble fuel using high-assay low-enriched uranium (HALEU). Its business model is intellectual property-driven, combining reactor licensing, long-term services (engineering, construction support, operator training), and recurring fuel supply revenue over a projected 60-year plant life. The company has not yet delivered any reactor or achieved final investment decisions, placing it squarely in the FOAK (first-of-a-kind) risk category. It relies on three anchor customers—Dow, Amazon, and Centrica—for a pipeline exceeding 11 GWe and 144 reactors, though all agreements remain contingent and non-binding in key respects, particularly the Centrica JDA. Revenue remains modest ($109.1 million in 2025), derived almost entirely from U.S. government grants (ARDP, DoE, DoD) and limited commercial contracts, while net losses have widened to $389.8 million—driven by heavy R&D, direct costs, and mark-to-market warrant liabilities. The offering of 42.9 million Class A shares at $17.50 implies $693.8 million in net proceeds, all earmarked to acquire newly issued Common Units from XERC, its operating subsidiary. This Up-C structure creates a complex capital architecture: Class B common stock represents 33.2% of voting power but zero economic rights, and the Tax Receivable Agreement commits the company to substantial future payments—up to $641.5 million over 15 years—based on anticipated tax benefits, with early termination triggering an immediate $439.3 million payment. Key risks are highly specific: dependence on DOE’s ARDP program ($438 million reimbursed to date, but budget period ends August 2026 and total award expires around 2030); unresolved HALEU supply constraints that could delay fuel qualification and reactor commissioning; and a material weakness in internal controls over financial reporting that persists despite hiring and process initiatives. Management brings deep nuclear policy and project delivery expertise—CEO J. Clay Sell’s tenure as Deputy Secretary of Energy and COO Dragan Popovic’s leadership of OPG’s SMR execution provide credibility—but the company’s success hinges on executing multiple interdependent regulatory milestones: NRC Construction Permit Application for Dow (expected Q1 2027), TX-1 Special Nuclear Material License (already obtained in February 2026), and eventual fuel qualification via irradiation testing at Idaho National Lab (campaign expected to conclude Q4 2026). With no equity financing history beyond private placements, no operating cash flow, and no near-term dividend policy, investors are betting exclusively on the viability of its technology roadmap, government partnership durability, and ability to convert design maturity into scalable, bankable projects—making this a high-risk, high-potential strategic bet on next-generation nuclear infrastructure.